These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35972550)

  • 21. Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma.
    Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Yamashita Y; Takamori H; Kanemitsu K; Baba H
    Cardiovasc Intervent Radiol; 2007; 30(5):912-21. PubMed ID: 17710478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma.
    Nagayama Y; Tanoue S; Inoue T; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
    Eur Radiol; 2020 Jan; 30(1):394-403. PubMed ID: 31312889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
    Baliyan V; Kordbacheh H; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Rigiroli F; Hoye J; Lerebours R; Lyu P; Lafata KJ; Zhang AR; Erkanli A; Mettu NB; Morgan DE; Samei E; Marin D
    Eur Radiol; 2023 Aug; 33(8):5779-5791. PubMed ID: 36894753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI vs. CT for pancreatic adenocarcinoma vascular invasion: comparative diagnostic test accuracy systematic review and meta-analysis.
    Jajodia A; Wang A; Alabousi M; Wilks C; Kulkarni A; van der Pol CB
    Eur Radiol; 2023 Oct; 33(10):6883-6891. PubMed ID: 37083741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
    Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
    AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
    [No Abstract]   [Full Text] [Related]  

  • 29. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy.
    Ciaravino V; Cardobi N; DE Robertis R; Capelli P; Melisi D; Simionato F; Marchegiani G; Salvia R; D'Onofrio M
    Anticancer Res; 2018 Aug; 38(8):4889-4895. PubMed ID: 30061265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
    Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
    Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?
    Noda Y; Pisuchpen N; Parakh A; Srinivas-Rao S; Kinowaki Y; Mino-Kenudson M; Kambadakone AR
    Br J Radiol; 2024 Feb; 97(1155):607-613. PubMed ID: 38305574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of
    Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
    J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer.
    Curvo-Semedo L; Portilha MA; Ruivo C; Borrego M; Leite JS; Caseiro-Alves F
    Acad Radiol; 2012 Feb; 19(2):203-13. PubMed ID: 22130088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9.
    Kim SS; Lee S; Lee HS; Bang S; Han K; Park MS
    Radiology; 2022 Jun; 303(3):548-556. PubMed ID: 35258374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer.
    Li XS; Fan HX; Zhu HX; Song YL; Zhou CW
    Eur Radiol; 2012 Mar; 22(3):617-24. PubMed ID: 21960157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
    Zimmermann C; Distler M; Jentsch C; Blum S; Folprecht G; Zöphel K; Polster H; Troost EGC; Abolmaali N; Weitz J; Baumann M; Saeger HD; Grützmann R
    Strahlenther Onkol; 2021 Jan; 197(1):19-26. PubMed ID: 32638040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma.
    Noda Y; Tochigi T; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2021 Jun; 46(6):2610-2619. PubMed ID: 33454806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.